A Trial of IDN-6556 in Post Orthotopic Liver Transplant for Chronic HCV

PHASE2CompletedINTERVENTIONAL
Enrollment

64

Participants

Timeline

Start Date

May 31, 2014

Primary Completion Date

February 15, 2018

Study Completion Date

March 9, 2018

Conditions
Liver FibrosisHepatic FibrosisLiver CirrhosisHepatic Cirrhosis
Interventions
DRUG

IDN-6556

DRUG

Placebo

Placebo control

Trial Locations (35)

10032

Columbia University Medical Center, New York

19104

University of Pennsylvania Milton Hershey Hospital, Philadelphia

19140

Temple University Hospital, Philadelphia

19141

Albert Einstein Medical Center, Philadelphia

20007

Georgetown University Hospital, Washington D.C.

21287

Johns Hopkins Sibley Memorial Hospital, Washington D.C.

John Hopkins Hospital, Baltimore

23226

Bon Secours St. Mary's Hospital of Richmond, Richmond

23249

McGuire DVAMC, Richmond

23602

Bon Secours Mary Immaculate Hospital, Newport News

30309

Piedmont Atlanta Hospital, Atlanta

32610

University of Florida, Gainesville

33136

University of Miami, Miami

40202

University of Louisville, Louisville

45267

University of Cincinnati Physicians Company, Cincinnati

46202

Indiana University, Indianapolis

48202

Henery Ford Health System, Detroit

60612

Rush University Medical Center, Chicago

60637

University of Chicago Medicine, Chicago

63104

Saint Louis University, St Louis

66160

University of Kansas Medical Center, Kansas City

70112

Tulane Health Science Center, New Orleans

70121

Ochsner Clinic, New Orleans

76104

Baylor All Saints Medical Center, Fort Worth

77030

Liver Associates of Texas, PA, Houston

University of Texas Health Science Center at Houston, Houston

VAMC/Baylor College of Medicine, Houston

84132

University of Utah, Salt Lake City

90095

UCLA Pfleger Liver Institute, Los Angeles

92037

Scripps Clinic, La Jolla

92118

Southern California Research Center, Coronado

92354

Loma Linda University Medical Center, Loma Linda

98104

University of Washington Harborview Medical Center, Seattle

02215

Beth Israel Deaconess Medical Center, Boston

07103

Rutgers New Jersey Medical School, Newark

Sponsors
All Listed Sponsors
lead

Conatus Pharmaceuticals Inc.

INDUSTRY

NCT02138253 - A Trial of IDN-6556 in Post Orthotopic Liver Transplant for Chronic HCV | Biotech Hunter | Biotech Hunter